Transverse colon cancer, stomach cancer, liver cancer, kidney cancer
Conditions
Interventions
experimental group:0.375% ropivacaine + morphine + dexamethasone
control group:Normal saline
Sponsors
Chongqing University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of liver cancer, adrenal tumor, gastric cancer, transverse colon cancer; 2. Proposed upper abdominal surgery: partial hepatectomy, partial adrenalectomy, radical resection of gastric cancer, radical resection of transverse colon cancer; 3. Aged 18-70 years, gender not limited; 4. Anesthesia Grade ASA I-III; 5. Voluntary cooperation, signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients allergic to local anesthetics; 2. Endocrine disorders; 3. Patients with mental illness; 4. Coagulation dysfunction; 5. Pregnant or lactating women; 6. Morbidly obese; patients with severe heart and lung diseases; 7. Puncture site infections; patients with immune diseases; 8. From a medical point of view, it is necessary for the subject to suspend the test; 9. The patient himself requests to stop the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6;Interleukin 10;cortisol;catecholamines; | — |
Secondary
| Measure | Time frame |
|---|---|
| Itchy skin;feel sick and vomit;Ramsay sedation score;VAS pain score; | — |
Countries
China
Contacts
Public ContactWei Chuang
Chongqing University Cancer Hospital
Outcome results
None listed